Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT02395172
Title	Avelumab in Non-Small Cell Lung Cancer (JAVELIN Lung 200)
Recruitment	Completed
Gender	both
Phase	Phase III
Variant Requirements	Yes
Sponsors	EMD Serono Research & Development Institute, Inc.
Indications	lung non-small cell carcinoma
Therapies	Avelumab Docetaxel
Age Groups:	adult
Covered Countries	USA \| TUR \| SVK \| ROU \| POL \| ITA \| ISR \| HUN \| HRV \| GBR \| FRA \| ESP \| DNK \| CZE \| CHE \| BRA \| BGR \| BEL \| AUS \| ARG